http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Byline Bank Included in U.S. News & World Report’s 2025-2026 Best Companies to Work For
-
Aclaris Therapeutics (ACRS) Added to the Russell 2000 and Russell 3000 Indexes
-
Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes
-
Sezzle Unveils Smarter Shopping Tools to Meet Rising Consumer Expectations
-
Citizens Financial Group Announces Second Quarter 2025 Earnings Conference Call Details
-
YURU COIN Officially Launches, Bringing Japan’s National Mascot Phenomenon into Web3
-
Xtra Energy Corp. Posts and Receives BLM Acceptance of Reclamation Bond, Clearing the Way for Immediate Development at the American Antimony Project
-
MADD Shares Lifesaving Tips for 4th of July Celebrations as Part of Safe Summer Campaign
-
Zai Lab Limited (ZLAB) Announces Positive Topline Phase 3 Results for Bemarituzumab
-
GCANRx Announces Uplisting to New Market Tier
-
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer
-
Usio Enters into Strategic Partnership with Mortgage Software Leader – Mortgage Automator
-
National Winners Named in the 23rd Annual eCYBERMISSION STEM Competition
-
MOUNTAIN DEW LAUNCHES "THIRST GUARDS" WITH COUNTRY MUSIC SUPERSTAR COLE SWINDELL AND LIMITED-EDITION PIT VIPER COLLABORATION
-
Liberty Star Embarks on 3D IP Survey at Red Rock Gold Project, SE Arizona
-
Laramide Resources Announces Private Placement
-
HII and C3 AI Forge Strategic Artificial Intelligence Partnership to Support US Navy Shipbuilding
-
CYCROWN Launches Dremax E-Bike: Torque/Cadence Switchable Mode with 720Wh Samsung Battery, Up to 65 Miles
-
IMAX Races to $28 Million Opening Weekend for “F1®: The Movie”
-
AbbVie (ABBV) to Acquire Capstan Therapeutics for $2.1 Billion
-
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology
-
ESGold Expands Montauban Mine Building to 4,000 sq. ft. Ahead of Key Operational Milestones
-
NFL Rookie Quarterback Dillon Gabriel Signs Endorsement Deal With Chrysler Brand
-
ReElement Technologies Expands Commercial Capabilities to Include Delivery of 99.99% - 99.999% Separated Rare Earth & Critical Minerals for U.S. Commercial and Defense Supply Chains
-
Lightchain AI Raises $21 Million and Enters Bonus Round Ahead of July 2025 Mainnet Launch
-
AbbVie (ABBV) Announces FDA's Acceptance of Allergan's Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM
-
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
-
Immutable and IMX Ecosystem Foundation Announce Major Airdrop to IMX Stakers
-
MDA Space (MDA) receives extension to contract with DFO
-
GOVERNMENT OF CANADA EXTENDS MDA SPACE CONTRACT PROVIDING CONTINUOUS SPACE-BASED MARITIME AWARENESS AND SECURITY
-
Avant Technologies (AVAI) and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting
-
Richtech Robotics (RR) Joint Venture Partner Secures $4M Sales Agreement to Expand Reach in Asia’s AI Robotics Market
-
Clene (CLNN) Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
-
Richtech Robotics Joint Venture Partner Secures $4M Sales Agreement to Expand Reach in Asia’s AI Robotics Market
-
AbbVie to Host Second-Quarter 2025 Earnings Conference Call
-
Leatt Corporation Announces Date of 2024 Annual General Meeting, Conference Call and Webcast
-
Spirent and Juniper Networks Collaborate to Showcase First Public UET Test
-
Visium Technologies Advances to OTCID Tier on OTC Markets, Demonstrating Growth and Transparency
-
BitMEX Study Reveals 90% Drop in Extreme Bitcoin Perpetual Futures Funding Rates Since 2016, Signalling Market Maturation
-
Avant Technologies and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting
-
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
-
Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment
-
Gcore powers launch of Funcom's Dune: Awakening with expanded LATAM infrastructure
-
BridgeBio Pharma (BBIO) Raises $300 Million Through Partial Capped Monetization of BEYONTTRA European Royalty
-
BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty
-
Palvella Therapeutics Added to Russell 3000® and Russell 2000® Indexes
-
Moderna (MRNA) Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
-
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
-
Novocure to Report Second Quarter 2025 Financial Results
-
CD&R Foundation Announces Grants to Five Non-Profit Organizations in New York City


